Vascular cognitive impairment
WM Van Der Flier, I Skoog, JA Schneider… - Nature reviews Disease …, 2018 - nature.com
The term vascular cognitive impairment (VCI) was introduced around the start of the new
millennium and refers to the contribution of vascular pathology to any severity of cognitive …
millennium and refers to the contribution of vascular pathology to any severity of cognitive …
Epidemiology of vascular dementia: nosology in a time of epiomics
FJ Wolters, MA Ikram - Arteriosclerosis, thrombosis, and vascular …, 2019 - Am Heart Assoc
The notion of what qualifies as vascular dementia has varied greatly since the first mention
of dementia after apoplexy in ancient literature. Current insight points towards a …
of dementia after apoplexy in ancient literature. Current insight points towards a …
The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids
W Xiao, J Su, X Gao, H Yang, R Weng, W Ni, Y Gu - Microbiome, 2022 - Springer
Background Chronic cerebral hypoperfusion (CCH) underlies secondary brain injury
following certain metabolic disorders and central nervous system (CNS) diseases …
following certain metabolic disorders and central nervous system (CNS) diseases …
[HTML][HTML] Culture, ethnicity, and level of education in Alzheimer's disease
M Rosselli, IV Uribe, E Ahne, L Shihadeh - Neurotherapeutics, 2022 - Elsevier
Alzheimer's disease (AD) is the most frequent cause of dementia, where the abnormal
accumulation of beta-amyloid (Aβ) and tau lead to neurodegeneration as well as loss of …
accumulation of beta-amyloid (Aβ) and tau lead to neurodegeneration as well as loss of …
Can we learn lessons from the FDA's approval of aducanumab?
On 7 June 2021, aducanumab was granted accelerated approval for the treatment of
Alzheimer disease (AD) by the FDA on the basis of amyloid-lowering effects considered …
Alzheimer disease (AD) by the FDA on the basis of amyloid-lowering effects considered …
The integration of inflammaging in age-related diseases
Aging is characterized by a morpho-functional adaptation, variably affecting major
physiological systems, depending on a complex interaction between genetic, environmental …
physiological systems, depending on a complex interaction between genetic, environmental …
Diabetes and cognitive impairment
LA Zilliox, K Chadrasekaran, JY Kwan… - Current diabetes …, 2016 - Springer
Abstract Both type 1 (T1DM) and type 2 diabetes mellitus (T2DM) have been associated with
reduced performance on multiple domains of cognitive function and with evidence of …
reduced performance on multiple domains of cognitive function and with evidence of …
[HTML][HTML] Mediterranean diet, cognitive function, and dementia: a systematic review of the evidence
SD Petersson, E Philippou - Advances in Nutrition, 2016 - Elsevier
A growing body of evidence suggests that adherence to the Mediterranean diet (MD) may
protect against cognitive decline and dementia. Many epidemiologic studies and several …
protect against cognitive decline and dementia. Many epidemiologic studies and several …
Aging, obesity, and inflammatory age-related diseases
D Frasca, BB Blomberg, R Paganelli - Frontiers in immunology, 2017 - frontiersin.org
The increase in the prevalence of obesity represents a worldwide phenomenon in all age
groups and is pathologically and genetically correlated with several metabolic and …
groups and is pathologically and genetically correlated with several metabolic and …
Neuroinflammation as a key driver of secondary neurodegeneration following stroke?
SM Stuckey, LK Ong, LE Collins-Praino… - International Journal of …, 2021 - mdpi.com
Ischaemic stroke involves the rapid onset of focal neurological dysfunction, most commonly
due to an arterial blockage in a specific region of the brain. Stroke is a leading cause of …
due to an arterial blockage in a specific region of the brain. Stroke is a leading cause of …